World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
80
Citations
29302
World Ranking
1605
National Ranking
801

Daniel E. Geraghty publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Daniel E. Geraghty sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 240 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Daniel E. Geraghty D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel E. Geraghty sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Daniel E. Geraghty is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research spans multiple aspects of medicine with a particular focus on immunology and microbiology. Key areas of study include immunology, infectious diseases, genetics, animal science and zoology, and molecular biology.

The main topics addressed in their work include:

  • SARS-CoV-2 and COVID-19 Research
  • T-cell and B-cell Immunology
  • Diabetes and associated disorders
  • Immune Cell Function and Interaction
  • Animal Virus Infections Studies
  • SARS-CoV-2 detection and testing
  • Pancreatic function and diabetes

Their research has been published extensively in a variety of venues. The most frequent publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • Scientific Reports
  • HLA
  • Research Square (Research Square)

Notable recent papers authored or co-authored by Geraghty exemplify a range of immunological studies and viral infection research. These include:

  • "Broadly neutralizing antibodies target the coronavirus fusion peptide," 2022, Science
  • "Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses," 2022, Cell Host & Microbe
  • "A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses," 2023, Science Translational Medicine
  • "Human leukocyte antigen HLA-C, HLA-G, HLA-F, and HLA-E placental profiles are altered in early severe preeclampsia and preterm birth with chorioamnionitis," 2022, American Journal of Obstetrics and Gynecology
  • "Broadly neutralizing antibodies target the coronavirus fusion peptide," 2022, bioRxiv (Cold Spring Harbor Laboratory)

Geraghty collaborates frequently with several researchers. Their most common co-authors include:

  • Chul-Woo Pyo
  • Lue Ping Zhao
  • Ruihan Wang
  • Terry P. Lybrand
  • Wyatt C. Nelson

Through these collaborations and their research output, Geraghty contributes to advancing knowledge in immunology, viral infections, and related medical fields. Their work, documented extensively in peer-reviewed journals and reputable scientific platforms, reflects engagement with critical contemporary issues in infectious disease and immune system function.

Best Publications

  • Nomenclature for factors of the HLA system, 2010.

    S G. E. Marsh;E. D. Albert;W. F. Bodmer;R. E. Bontrop

  • Complete sequence and gene map of a human major histocompatibility complex

    S Beck;D Geraghty;H Inoko;L Rowen

  • HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.

    Ni Lee;Manuel Llano;Marta Carretero;Akiko Ishitani

  • A second lineage of mammalian major histocompatibility complex class I genes

    Seiamak Bahram;Maureen Bresnahan;Daniel E. Geraghty;Thomas Spies

  • Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002

    Steven G. E. Marsh;Peter Parham;Bo Dupont;Daniel E. Geraghty

  • Nomenclature for factors of the HLA system, 2004

    Steven G.E. Marsh;E. D. Albert;W. F. Bodmer;R. E. Bontrop

  • Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens.

    Akiko Ishitani;Daniel E. Geraghty

  • Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

    Sarah Cooley;Daniel J. Weisdorf;Lisbeth A. Guethlein;John P. Klein

  • A HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I GENE THAT ENCODES A PROTEIN WITH A SHORTENED CYTOPLASMIC SEGMENT

    Daniel E. Geraghty;Beverly H. Koller;Harry T. Orr

  • HLA-E Surface Expression Depends on Binding of TAP-Dependent Peptides Derived from Certain HLA Class I Signal Sequences

    Ni Lee;David R. Goodlett;Akiko Ishitani;Hans Marquardt

  • The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.

    Katharine C. Hsu;Shohei Chida;Daniel E. Geraghty;Bo Dupont

  • A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.

    Tomoyuki Fujii;Akiko Ishitani;Daniel E. Geraghty

  • Protein Expression and Peptide Binding Suggest Unique and Interacting Functional Roles for HLA-E, F, and G in Maternal-Placental Immune Recognition

    Akiko Ishitani;Noriko Sageshima;Ni Lee;Natalia Dorofeeva

  • Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes

    Michael C. Carroll;Philip Katzman;Elizabeth M. Alicot;Beverly H. Koller

  • HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer

    Manuel Llano;Ni Lee;Francisco Navarro;Pilar García

  • The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells

    Francisco Navarro;Manuel Llano;Teresa Bellón;Marco Colonna

  • Nomenclature for factors of the HLA system, 2002

    Steven G. E. Marsh;Ekkehard D. Albert;Walter F. Bodmer;Ronald E. Bontrop

  • Activation of NK cells by an endocytosed receptor for soluble HLA-G.

    Sumati Rajagopalan;Yenan T Bryceson;Shanmuga P Kuppusamy;Daniel E Geraghty

  • Reprogramming of CTLs into natural killer–like cells in celiac disease

    Bertrand Meresse;Shane A. Curran;Cezary Ciszewski;Gerasim Orbelyan

  • The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association

    Ni Lee;Alison R. Malacko;Akiko Ishitani;Ming-Chu Chen

  • Nomenclature for factors of the HLA system, 2004.

    Unknown

  • Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

    S Cooley;DJ Weisdorf;LA Guethlein;JP Klein

Frequent Co-Authors

Peter Parham
Peter Parham Stanford University
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
Mary Carrington
Mary Carrington Ragon Institute of MGH, MIT and Harvard
M. Juliana McElrath
M. Juliana McElrath University of Washington
Åke Lernmark
Åke Lernmark Lund University
Beverly H. Koller
Beverly H. Koller University of North Carolina at Chapel Hill
Steven G.E. Marsh
Steven G.E. Marsh University College London
Bo Dupont
Bo Dupont Memorial Sloan Kettering Cancer Center
Harry T. Orr
Harry T. Orr University of Minnesota
John A. Hansen
John A. Hansen Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology in the USA can open doors to various healthcare roles, particularly in nursing and advanced clinical practice. Many students consider specializing further by exploring programs such as the best online pmhnp programs, which emphasize strong clinical placement opportunities for psychiatric mental health nurse practitioners. This ensures hands-on experience essential for career advancement.

Cost is another crucial factor when selecting a program. To balance quality with affordability, prospective students often review the cheapest pmhnp programs. These programs offer pathways that are budget-friendly without compromising the core curriculum required for certification and practice.

For those advancing beyond a master's, a Doctor of Nursing Practice (DNP) representation links education to potential earnings. Understanding regional differences through resources like the dnp salary by state guide helps graduates assess where their degree could yield the best financial return.

Nurses looking to expand their expertise often transition between specialties, such as moving from Family Nurse Practitioner (FNP) roles to Acute Care Nurse Practitioner (ACNP) positions. Guidance on this career shift is available in detailed tutorials like fnp to acnp, which outline steps, certifications, and new skills required.

Best Scientists Citing Daniel E. Geraghty

Trending Scientists

Recently Published Articles